欢迎访问西亚试剂!
西亚试剂banner
西亚试剂banner
西亚试剂banner

当前位置:首页 > 新闻中心

西亚试剂: Mechanism for the Upregulation of EGF Receptor Levels in G

发布时间:2025-06-23

A Mechanism for the Upregulation of EGF Receptor Levels in Glioblastomas

Jingwen Zhang, Marc A. Antonyak, Garima Singh, Richard A. Cerione

Tissue transglutaminase (tTG) is a GTP-binding protein/acyltransferase whose expression is upregulated in glioblastoma and associated with decreased patient survival. Here, we delineate a unique mechanism by which tTG contributes to the development of gliomas by using two glioblastoma cell lines, U87 and LN229, whose growth and survival are dependent on tTG. We show that tTG significantly enhances the signaling activity and lifespan of EGF receptors (EGFRs) in these brain cancer cells. Moreover, overexpressing tTG in T98G glioblastoma cells that normally express low levels of tTG caused a marked upregulation of EGFR expression and transforming activity. Furthermore, we show that tTG accentuates EGFR signaling by blocking c-Cbl-catalyzed EGFR ubiquitylation through the ability of tTG to bind GTP and adopt a specific conformation that enables it to interact with c-Cbl. These findings demonstrate that tTG contributes to gliomagenesis by interfering with EGFR downregulation and, thereby, promoting transformation.

上一篇:西亚试剂:The role of DNA shape in protein–DNA recognition
下一篇:仪征化纤新PBT树脂装置正式投产
版权所有:山东西亚化学有限公司

鲁ICP备20015914号-4